{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T19:12:37Z","timestamp":1768936357246,"version":"3.49.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:00:00Z","timestamp":1561507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["20180101138JC"],"award-info":[{"award-number":["20180101138JC"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2019.00407","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T10:18:39Z","timestamp":1561544319000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Predictive Factors of Recurrence for Multifocal Papillary Thyroid Microcarcinoma With Brafv600e Mutation: A Single Center Study of 1,207 Chinese Patients"],"prefix":"10.3389","volume":"10","author":[{"given":"Shuai","family":"Xue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peisong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meishan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jama.2017.2719","article-title":"Trends in thyroid cancer incidence and mortality in the United States, 1974-2013","volume":"317","author":"Lim","year":"2017","journal-title":"JAMA."},{"key":"B2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nrendo.2016.110","article-title":"The changing incidence of thyroid cancer","volume":"12","author":"Kitahara","year":"2016","journal-title":"Nat Rev Endocrinol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/1097-0142(19890301)63:5<908::AID-CNCR2820630520>3.0.CO;2-I","article-title":"The WHO histological classification of thyroid tumors: a commentary on the second edition","volume":"63","author":"Hedinger","year":"1989","journal-title":"Cancer."},{"key":"B4","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1089\/thy.2015.0429","article-title":"Clinical and pathologic predictors of lymph node metastasis and recurrence in papillary thyroid microcarcinoma","volume":"26","author":"Siddiqui","year":"2016","journal-title":"Thyroid."},{"key":"B5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s12020-014-0350-7","article-title":"Nodal metastasis and recurrence in papillary thyroid microcarcinoma","volume":"48","author":"Pisanu","year":"2015","journal-title":"Endocrine."},{"key":"B6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1089\/thy.2015.0391","article-title":"BRAF(V600E) is correlated with recurrence of papillary thyroid microcarcinoma: a systematic review, multi-institutional primary data analysis, and meta-analysis","volume":"26","author":"Chen","year":"2016","journal-title":"Thyroid."},{"key":"B7","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/1471-2407-8-296","article-title":"Prognostic parameters for recurrence of papillary thyroid microcarcinoma","volume":"8","author":"Kim","year":"2008","journal-title":"BMC Cancer."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.3390\/ijms18081756","article-title":"Galectin-3 performance in histologic a cytologic assessment of thyroid nodules: a systematic review and meta-analysis","volume":"18","author":"Trimboli","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1002\/cncr.26425","article-title":"A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma","volume":"118","author":"Niemeier","year":"2012","journal-title":"Cancer."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid."},{"key":"B11","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1210\/er.2007-0007","article-title":"BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications","volume":"28","author":"Xing","year":"2007","journal-title":"Endocr Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4390","DOI":"10.1210\/jc.2012-1775","article-title":"The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study","volume":"97","author":"Elisei","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1007\/s00268-017-4134-0","article-title":"Radioactive iodine ablation decrease recurrences in papillary thyroid microcarcinoma with lateral lymph node metastasis in Chinese patients","volume":"41","author":"Xue","year":"2017","journal-title":"World J Surg."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1089\/thy.2009.0110","article-title":"Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer","volume":"19","author":"Cooper","year":"2009","journal-title":"Thyroid."},{"key":"B15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cca.2019.01.017","article-title":"Detection of BRAF V600E mutation in fine-needle aspiration fluid of papillary thyroid carcinoma by droplet digital PCR","volume":"491","author":"Xu","year":"2019","journal-title":"Clin Chim Acta."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e0167414","DOI":"10.1371\/journal.pone.0167414","article-title":"Clinicopathological features and prognosis of papillary thyroid microcarcinoma for surgery and relationships with the BRAFV600E mutational status and expression of angiogenic factors","volume":"11","author":"Shi","year":"2016","journal-title":"PLoS ONE."},{"key":"B17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.oraloncology.2018.07.002","article-title":"Low versus high activity radioiodine remnant ablation for differentiated thyroid carcinoma with gross extrathyroidal extension invading only strap muscles","volume":"84","author":"Park","year":"2018","journal-title":"Oral Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1089\/thy.2012.0567","article-title":"Impact of degree of extrathyroidal extension of disease on papillary thyroid cancer outcome","volume":"24","author":"Radowsky","year":"2014","journal-title":"Thyroid."},{"key":"B19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.oraloncology.2017.03.008","article-title":"Extrathyroidal extension-what does it mean","volume":"68","author":"Shaha","year":"2017","journal-title":"Oral Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1245\/s10434-018-6563-x","article-title":"Extrathyroidal extension: does strap muscle invasion alone influence recurrence and survival in patients with differentiated thyroid cancer?","volume":"25","author":"Amit","year":"2018","journal-title":"Ann Surg Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1089\/thy.2018.0300","article-title":"A relook at the T stage of differentiated thyroid carcinoma with a focus on gross extrathyroidal extension","volume":"29","author":"Song","year":"2019","journal-title":"Thyroid."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.oraloncology.2016.12.004","article-title":"Can ratio of the biggest tumor diameter to total tumor diameter be a new parameter in the differential diagnosis of agressive and favorable multifocal papillary thyroid microcarcinoma?","volume":"65","author":"Tam","year":"2017","journal-title":"Oral Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1530\/EJE-12-0105","article-title":"Scoring system for predicting recurrences in patients with papillary thyroid microcarcinoma","volume":"167","author":"Buffet","year":"2012","journal-title":"Eur J Endocrinol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3349\/ymj.2015.56.2.355","article-title":"Total surface area is useful for differentiating between aggressive and favorable multifocal papillary thyroid carcinomas","volume":"56","author":"Pyo","year":"2015","journal-title":"Yonsei Med J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1038\/s41598-017-02165-6","article-title":"Total tumour diameter is superior to unifocal diameter as a predictor of papillary thyroid microcarcinoma prognosis","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1245\/s10434-012-2654-2","article-title":"Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma","volume":"20","author":"Zhao","year":"2013","journal-title":"Ann Surg Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s12020-016-0955-0","article-title":"Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer","volume":"53","author":"Tam","year":"2016","journal-title":"Endocrine."},{"key":"B28","doi-asserted-by":"publisher","first-page":"526","DOI":"10.4158\/EP161488.OR","article-title":"Should multifocal papillary thyroid carcinomas classified as T1a with a tumor diameter sum of 1 to 2 centimeters be reclassified as T1b?","volume":"23","author":"Tam","year":"2017","journal-title":"Endocr Pract."},{"key":"B29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1530\/ERC-15-0408","article-title":"Chronic lymphocytic thyroiditis and BRAF V600E in papillary thyroid carcinoma","volume":"23","author":"Kim","year":"2016","journal-title":"Endocr Relat Cancer."},{"key":"B30","doi-asserted-by":"publisher","first-page":"393","DOI":"10.14639\/0392-100X-1709","article-title":"Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients","volume":"37","author":"Liang","year":"2017","journal-title":"Acta Otorhinolaryngol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3803\/EnM.2018.33.4.473","article-title":"Associations between hashimoto thyroiditis and clinical outcomes of papillary thyroid cancer: a meta-analysis of observational studies","volume":"33","author":"Moon","year":"2018","journal-title":"Endocrinol Metab."},{"key":"B32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/hed.23854","article-title":"Combined effect of Hashimoto's thyroiditis and BRAF(V600E) mutation status on aggressiveness in papillary thyroid cancer","volume":"38","author":"Kim","year":"2016","journal-title":"Head Neck."},{"key":"B33","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s10147-014-0754-7","article-title":"Does papillary thyroid carcinoma have a better prognosis with or without Hashimoto thyroiditis?","volume":"20","author":"Kwak","year":"2015","journal-title":"Int J Clin Oncol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"E1019","DOI":"10.1002\/hed.24149","article-title":"Potential relationship between Hashimoto's thyroiditis and BRAF(V600E) mutation status in papillary thyroid cancer","volume":"38","author":"Zeng","year":"2016","journal-title":"Head Neck."},{"key":"B35","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.tem.2014.09.001","article-title":"Hashimoto's thyroiditis and papillary thyroid cancer: are they immunologically linked?","volume":"25","author":"Ehlers","year":"2014","journal-title":"Trends Endocrinol Metab."},{"key":"B36","doi-asserted-by":"publisher","first-page":"203","DOI":"10.20892\/j.issn.2095-3941.2017.0051","article-title":"2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma","volume":"14","author":"Gao","year":"2017","journal-title":"Cancer Biol Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.surg.2011.02.004","article-title":"Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: influence on serum thyroglobulin level, recurrence rate, and postoperative complications","volume":"151","author":"So","year":"2012","journal-title":"Surgery."},{"key":"B38","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s00268-015-3346-4","article-title":"The effectiveness of radioactive iodine remnant ablation for papillary thyroid microcarcinoma: a systematic review and meta-analysis","volume":"40","author":"Hu","year":"2016","journal-title":"World J Surg."},{"key":"B39","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/cen.12034","article-title":"Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma","volume":"78","author":"Kim","year":"2013","journal-title":"Clin Endocrinol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s12022-018-9518-7","article-title":"The prevalence of extranodal extension in papillary thyroid cancer based on the size of the metastatic node: adverse histologic features are not limited to larger lymph nodes","volume":"29","author":"Rowe","year":"2018","journal-title":"Endocr Pathol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1001\/jama.2013.3190","article-title":"Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer","volume":"309","author":"Xing","year":"2013","journal-title":"JAMA."},{"key":"B42","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.amjsurg.2011.02.013","article-title":"Is the BRAF(V600E) mutation useful as a predictor of preoperative risk in papillary thyroid cancer?","volume":"203","author":"Nam","year":"2012","journal-title":"Am J Surg."},{"key":"B43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s12022-017-9470-y","article-title":"Frequent BRAF (V600E) and absence of TERT promoter mutations characterize sporadic pediatric papillary thyroid carcinomas in Japan","volume":"28","author":"Oishi","year":"2017","journal-title":"Endocr Pathol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/hed.21142","article-title":"Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAF(V600E) mutation, clinicopathological features, and immunohistochemical findings","volume":"32","author":"Park","year":"2010","journal-title":"Head Neck."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1210\/jc.2008-0607","article-title":"BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study","volume":"93","author":"Elisei","year":"2008","journal-title":"J Clin Endocrinol Metab."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00407\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T12:20:34Z","timestamp":1569327634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00407\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,26]]},"references-count":45,"alternative-id":["10.3389\/fendo.2019.00407"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2019.00407","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,26]]},"article-number":"407"}}